Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index; 11 of the 24 sources its claims cite were checked for support.

GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings

Open access

Abstract

INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. METHODS: FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. RESULT: Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0-94.5] and specificity 91.1% [95% CI: 82.8-99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. CONCLUSION: Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates.

Overview

CoChat Summary

TL;DR

This study evaluated GeneXpert MTB/RIF on concentrated fine needle aspirates from 143 presumptive tuberculous lymphadenitis (TBL) cases in Southwest Ethiopia and found high diagnostic accuracy versus a composite bacteriological reference standard. Xpert was much more sensitive than smear microscopy and also detected rifampicin resistance in a small subset of positives.

Key findings

  • Among 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard; Xpert detected MTBC in 60.1% (86/143) of presumptive cases.
  • Compared with the composite reference standard, Xpert had 87.8% sensitivity (95% CI 81.0–94.5) and 91.1% specificity (95% CI 82.8–99.4).
  • Smear microscopy had 27.8% sensitivity, and cytology had 80.0% sensitivity but only 57.8% specificity.
  • Rifampicin resistance was identified in 4.7% (4/86) of Xpert-positive cases; 53.5% (46/86) of Xpert-positive samples were “very low” and 44.2% (38/86) were “low” semi-quantitative categories.

Methods

  • Prospective diagnostic study at Jimma University Specialized Hospital, Southwest Ethiopia; 143 consecutive outpatients clinically suspected of TBL were enrolled between May and September 2013.
  • Fine needle aspirates were split for cytology, Ziehl-Neelsen smear microscopy, Löwenstein-Jensen culture, and Xpert MTB/RIF after NALC/NaOH concentration and centrifugation; Capilia TB-Neo was used to distinguish MTBC from NTM.
  • Diagnostic performance was assessed using composite bacteriological methods (culture and/or smear microscopy) as the reference standard, with sensitivity, specificity, and predictive values calculated in SPSS.

Limitations

  • The paper states that culture on LJ medium and/or smear microscopy is not sufficient to detect all TBL cases, so the reference standard could miss true cases.
  • The authors note they did not include clinical outcomes, and they suggest future studies using liquid culture, histology, and/or clinical response to treatment as better standards.
  • They cultured only one NTM isolate and did not speciate it, so the study cannot assess the contribution of NTM lymphadenitis in Ethiopia.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0137471

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 Diagnostic accuracy of Xpert for detection of M. tuberculosis from patients with suspected TBL. TBL = tuberculous lymphadenitis, FNA = fine needle aspirate, + = positive,— = negative.
Fig 1 Diagnostic accuracy of Xpert for detection of M. tuberculosis from patients with suspected TBL. TBL = tuberculous lymphadenitis, FNA = fine needle aspirate, + = positive,— = negative.CC BY · PubMed Central

Verification

Claims the paper makes

5 Valid · 1 Not valid · 8 Not checked · 63 Own results and interpretations

43 more claims

Create a free account to see all 77 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 18
  • Probably not a substantial claim. 15

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Cited by

See all 85

Metadata

Authors
Tadesse, M., Abebe, G., Abdissa, K., Aragaw, D., Abdella, K., Bekele, A., Bezabih, M., Apers, L., de Jong, B. C., & Rigouts, L.
Affiliations
  • Jimma University (ET)
  • Instituut voor Tropische Geneeskunde (BE)
  • University of Antwerp (BE)
Corresponding author
Abebe, Gemeda
Venue
PLoS ONE
Published
2015-09-14
Volume
10
Issue
9
Pages
e0137471
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2191708934
Cited by
85
References
21
Citations by year
2026: 5 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 8 · 2020: 12 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 5
FWCI
5.46
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Jimma University
  • Vlaamse Interuniversitaire Raad
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
Keywords
tuberculous lymphadenitis, Xpert MTB/RIF, extrapulmonary tuberculosis, Mycobacterium tuberculosis complex, smear microscopy, cytology, sensitivity and specificity, rifampicin resistance, nontuberculous mycobacteria, Ethiopia, molecular tuberculosis diagnosis, N-acetylcysteine
MeSH terms
Adolescent, Adult, Bacteriological Techniques, Ethiopia, Female, Humans, Lymph Nodes, Male, Middle Aged, Mycobacterium tuberculosis, Prognosis, Rifampin, Sputum, Tuberculosis, Lymph Node, Biopsy, Fine-Needle, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings. https://app.cochat.ai/papers/10.1371/journal.pone.0137471
The paper
Tadesse, M., Abebe, G., Abdissa, K., Aragaw, D., Abdella, K., Bekele, A., Bezabih, M., Apers, L., de Jong, B. C., & Rigouts, L. (2015). GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings. PLoS ONE. https://doi.org/10.1371/journal.pone.0137471

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.